Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Biogen (NASDAQ: BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) Grows Presence in China with the Approval of TECFIDERA for Treatment of Relapsing Multiple Sclerosis
- New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis
- 'A Pump and Dump SPAC Scam': Quantumscape (QS), Backed by Bill Gates and Volkswagen, Falls 10% On a Short Report from Scorpion Capital